Y-Intercept (HK)’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Buy |
870,181
+822,799
| +1,737% | +$14.1M | 0.36% | 25 |
|
|
2025
Q1 | $3.02M | Buy |
47,382
+38,292
| +421% | +$2.44M | 0.2% | 108 |
|
|
2024
Q4 | $1.11M | Buy |
9,090
+1,143
| +14% | +$139K | 0.07% | 389 |
|
|
2024
Q3 | $993K | Sell |
7,947
-29,809
| -79% | -$3.72M | 0.06% | 452 |
|
|
2024
Q2 | $5.97M | Buy |
37,756
+28,568
| +311% | +$4.51M | 0.33% | 49 |
|
|
2024
Q1 | $1.19M | Buy |
+9,188
| New | +$1.19M | 0.09% | 319 |
|
|
2023
Q2 | – | Sell |
-13,926
| Closed | -$1.92M | – | 1703 |
|
|
2023
Q1 | $1.92M | Sell |
13,926
-2,567
| -16% | -$354K | 0.22% | 94 |
|
|
2022
Q4 | $2.14M | Buy |
+16,493
| New | +$2.14M | 0.32% | 48 |
|
|
2022
Q3 | – | Sell |
-9,962
| Closed | -$747K | – | 1252 |
|
|
2022
Q2 | $747K | Buy |
9,962
+5,917
| +146% | +$444K | 0.1% | 303 |
|
|
2022
Q1 | $316K | Sell |
4,045
-4,056
| -50% | -$317K | 0.07% | 428 |
|
|
2021
Q4 | $729K | Sell |
8,101
-597
| -7% | -$53.7K | 0.17% | 172 |
|
|
2021
Q3 | $804K | Buy |
+8,698
| New | +$804K | 0.15% | 224 |
|
|
2021
Q2 | – | Sell |
-6,585
| Closed | -$481K | – | 881 |
|
|
2021
Q1 | $481K | Buy |
6,585
+2,495
| +61% | +$182K | 0.13% | 265 |
|
|
2020
Q4 | $702K | Buy |
+4,090
| New | +$702K | 0.3% | 86 |
|